{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T14:40:08Z","timestamp":1750603208159,"version":"3.41.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,22]]},"DOI":"10.7759\/cureus.86534","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T14:23:42Z","timestamp":1750602222000},"source":"Crossref","is-referenced-by-count":0,"title":["Factors Associated With Mortality in Leukemia and Lymphoma With COVID-19: A National Inpatient Sample Analysis (2020\u20132021)"],"prefix":"10.7759","author":[{"given":"Saketh","family":"Palasamudram Shekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barath Prashanth","family":"Sivasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diviya Bharathi","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husna","family":"Qadeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibthisam","family":"Ismail Sharieff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhea","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhu","family":"Chandra Pokhriyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amulya","family":"Bellamkonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamtha","family":"Balla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutul","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai M","year":"2020","unstructured":"Dai M, Liu D, Liu M, et al.. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020, 10:783-91. 10.1158\/2159-8290.CD-20-0422","journal-title":"Cancer Discov"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33243","article-title":"Multivariate mortality analyses in COVID-19: comparing patients with cancer and patients without cancer in Louisiana","volume":"127","author":"Lunski MJ","year":"2021","unstructured":"Lunski MJ, Burton J, Tawagi K, et al.. Multivariate mortality analyses in COVID-19: comparing patients with cancer and patients without cancer in Louisiana. Cancer. 2021, 127:266-74. 10.1002\/cncr.33243","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864298","article-title":"CD8+ T cells in SARS-CoV-2 induced disease and cancer\u2014clinical perspectives","volume":"13","author":"Mortezaee K","year":"2022","unstructured":"Mortezaee K, Majidpoor J. CD8+ T cells in SARS-CoV-2 induced disease and cancer\u2014clinical perspectives. Front Immunol. 2022, 13:864298. 10.3389\/fimmu.2022.864298","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063374","article-title":"CD8+ T cell senescence: lights and shadows in viral infections, autoimmune disorders and cancer","volume":"23","author":"Tedeschi V","year":"2022","unstructured":"Tedeschi V, Paldino G, Kunkl M, Paroli M, Sorrentino R, Tuosto L, Fiorillo MT. CD8+ T cell senescence: lights and shadows in viral infections, autoimmune disorders and cancer. Int J Mol Sci. 2022, 23:3374. 10.3390\/ijms23063374","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi S","year":"2020","unstructured":"De Biasi S, Meschiari M, Gibellini L, et al.. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020, 11:3434. 10.1038\/s41467-020-17292-4","journal-title":"Nat Commun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01004-5","article-title":"Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis","volume":"23","author":"Hardy N","year":"2023","unstructured":"Hardy N, Vegivinti CT, Mehta M, et al.. Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis. Clin Exp Med. 2023, 23:1945-59. 10.1007\/s10238-023-01004-5","journal-title":"Clin Exp Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01177-0","article-title":"COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)","volume":"14","author":"Pagano L","year":"2021","unstructured":"Pagano L, Salmanton-Garc\u00eda J, Marchesi F, et al.. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol. 2021, 14:168. 10.1186\/s13045-021-01177-0","journal-title":"J Hematol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.13117","article-title":"Haematological malignancies implications during the times of the COVID-19 pandemic","volume":"22","author":"Papakonstantinou E","year":"2021","unstructured":"Papakonstantinou E, Dragoumani K, Efthimiadou A, et al.. Haematological malignancies implications during the times of the COVID-19 pandemic. Oncol Lett. 2021, 22:856. 10.3892\/ol.2021.13117","journal-title":"Oncol Lett"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012251","article-title":"COVID-19 in patients with hematologic malignancy","volume":"140","author":"Langerbeins P","year":"2022","unstructured":"Langerbeins P, Hallek M. COVID-19 in patients with hematologic malignancy. Blood. 2022, 140:236-52. 10.1182\/blood.2021012251","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.01.001","article-title":"Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients","volume":"39","author":"Abdul-Jawad S","year":"2021","unstructured":"Abdul-Jawad S, Ba\u00f9 L, Alaguthurai T, et al.. Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients. Cancer Cell. 2021, 39:257-75.e6. 10.1016\/j.ccell.2021.01.001","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280847","article-title":"COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)","volume":"108","author":"Marchesi F","year":"2023","unstructured":"Marchesi F, Salmanton-Garc\u00eda J, Emarah Z, et al.. COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA). Haematologica. 2023, 108:22-33. 10.3324\/haematol.2022.280847","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000538","article-title":"Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study","volume":"5","author":"Regalado-Artamendi I","year":"2021","unstructured":"Regalado-Artamendi I, Jim\u00e9nez-Ubieto A, Hern\u00e1ndez-Rivas J\u00c1, et al.. Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study. Hemasphere. 2021, 5:e538. 10.1097\/HS9.0000000000000538","journal-title":"Hemasphere"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0836-7","article-title":"COVID-19 in persons with haematological cancers","volume":"34","author":"He W","year":"2020","unstructured":"He W, Chen L, Chen L, et al.. COVID-19 in persons with haematological cancers. Leukemia. 2020, 34:1637-45. 10.1038\/s41375-020-0836-7","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.3980","article-title":"Editorial concern\u2014possible reporting of the same patients with COVID-19 in different reports","volume":"323","author":"Bauchner H","year":"2020","unstructured":"Bauchner H, Golub RM, Zylke J. Editorial concern\u2014possible reporting of the same patients with COVID-19 in different reports. JAMA. 2020, 323:1256. 10.1001\/jama.2020.3980","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira A","year":"2020","unstructured":"Vijenthira A, Gong IY, Fox TA, et al.. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020, 136:2881-92. 10.1182\/blood.2020008824","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1280271","article-title":"SARS-CoV-2 and chronic myeloid leukemia: a systematic review","volume":"10","author":"Ali EA","year":"2023","unstructured":"Ali EA, Al-Sadi A, Al-Maharmeh Q, et al.. SARS-CoV-2 and chronic myeloid leukemia: a systematic review. Front Med (Lausanne). 2023, 10:1280271. 10.3389\/fmed.2023.1280271","journal-title":"Front Med (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005691","article-title":"A prognostic model for patients with lymphoma and COVID-19: a\u00a0multicentre cohort study","volume":"6","author":"Visco C","year":"2022","unstructured":"Visco C, Marcheselli L, Mina R, et al.. A prognostic model for patients with lymphoma and COVID-19: a\u00a0multicentre cohort study. Blood Adv. 2022, 6:327-38. 10.1182\/bloodadvances.2021005691","journal-title":"Blood Adv"},{"key":"ref18","unstructured":"HCUP-US NIS overview. (2024). Accessed. March 5, 2024: https:\/\/hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1446482","article-title":"COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)","volume":"14","author":"Sivasubramanian BP","year":"2024","unstructured":"Sivasubramanian BP, Joshi S, Ravikumar DB, et al.. COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021). Front Oncol. 2024, 14:1446482. 10.3389\/fonc.2024.1446482","journal-title":"Front Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2025.03.006","article-title":"Analyzing two decades of leukemia mortality in the U.S. (1999-2020). [IN PRESS]","author":"Aziz N","year":"2025","unstructured":"Aziz N, Nabi W, Khan M, et al.. Analyzing two decades of leukemia mortality in the U.S. (1999-2020). [IN PRESS]. Clin Lymphoma Myeloma Leuk. 2025, 10.1016\/j.clml.2025.03.006","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref21","article-title":"ICD-10 International Statistical Classification of Diseases and Related Health Problems, Tenth Edition. Volume 1: Tabular List","author":"World Health Organization","year":"1992","unstructured":"World Health Organization. ICD-10 International Statistical Classification of Diseases and Related Health Problems, Tenth Edition. Volume 1: Tabular List. World Health Organization, Geneva, Switzerland; 1992."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2024.2381174","article-title":"The changing landscape of geriatric care in acute myeloid leukemia: a 5-year analysis of inpatient mortality predictors, trends in mortality, and chemotherapy use","volume":"37","author":"Bodla ZH","year":"2024","unstructured":"Bodla ZH, Hashmi M, Niaz F, et al.. The changing landscape of geriatric care in acute myeloid leukemia: a 5-year analysis of inpatient mortality predictors, trends in mortality, and chemotherapy use. Proc (Bayl Univ Med Cent). 2024, 37:813-21. 10.1080\/08998280.2024.2381174","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12090","article-title":"Generalizing observational study results: applying propensity score methods to complex surveys","volume":"49","author":"Dugoff EH","year":"2014","unstructured":"Dugoff EH, Schuler M, Stuart EA. Generalizing observational study results: applying propensity score methods to complex surveys. Health Serv Res. 2014, 49:284-303. 10.1111\/1475-6773.12090","journal-title":"Health Serv Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01363-1","article-title":"The intersection of COVID-19 and cancer: signaling pathways and treatment implications","volume":"20","author":"Zong Z","year":"2021","unstructured":"Zong Z, Wei Y, Ren J, Zhang L, Zhou F. The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Mol Cancer. 2021, 20:76. 10.1186\/s12943-021-01363-1","journal-title":"Mol Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.retram.2023.103407","article-title":"Bone marrow alterations in COVID-19 infection: the root of hematological problems","volume":"71","author":"Zeylabi F","year":"2023","unstructured":"Zeylabi F, Nameh Goshay Fard N, Parsi A, Pezeshki SM. Bone marrow alterations in COVID-19 infection: the root of hematological problems. Curr Res Transl Med. 2023, 71:103407. 10.1016\/j.retram.2023.103407","journal-title":"Curr Res Transl Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055137","article-title":"Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study","volume":"12","author":"Page JH","year":"2022","unstructured":"Page JH, Londhe AA, Brooks C, et al.. Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study. BMJ Open. 2022, 12:e055137. 10.1136\/bmjopen-2021-055137","journal-title":"BMJ Open"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2103-72","article-title":"The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients","volume":"51","author":"Karata\u015f A","year":"2021","unstructured":"Karata\u015f A, Malkan \u00dcY, Velet M, et al.. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients. Turk J Med Sci. 2021, 51:1647-52. 10.3906\/sag-2103-72","journal-title":"Turk J Med Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-020-00170-6","article-title":"Leukemia incidence trends at the global, regional, and national level between 1990 and 2017","volume":"9","author":"Dong Y","year":"2020","unstructured":"Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y, Wang Q. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020, 9:14. 10.1186\/s40164-020-00170-6","journal-title":"Exp Hematol Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01074","article-title":"Outcomes of COVID-19 in patients with cancer: report from the National COVID Cohort Collaborative (N3C)","volume":"39","author":"Sharafeldin N","year":"2021","unstructured":"Sharafeldin N, Bates B, Song Q, et al.. Outcomes of COVID-19 in patients with cancer: report from the National COVID Cohort Collaborative (N3C). J Clin Oncol. 2021, 39:2232-46. 10.1200\/JCO.21.01074","journal-title":"J Clin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2018.10.011","article-title":"Aging, inflammation and cancer","volume":"40","author":"Bottazzi B","year":"2018","unstructured":"Bottazzi B, Riboli E, Mantovani A. Aging, inflammation and cancer. Semin Immunol. 2018, 40:74-82. 10.1016\/j.smim.2018.10.011","journal-title":"Semin Immunol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.004","article-title":"The SARS-CoV-2 outbreak: what we know","volume":"94","author":"Wu D","year":"2020","unstructured":"Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. 2020, 94:44-8. 10.1016\/j.ijid.2020.03.004","journal-title":"Int J Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2108-239","article-title":"COVID-19 and sepsis","volume":"51","author":"Ko\u00e7ak Tufan Z","year":"2021","unstructured":"Ko\u00e7ak Tufan Z, Kayaaslan B, Mer M. COVID-19 and sepsis. Turk J Med Sci. 2021, 51:3301-11. 10.3906\/sag-2108-239","journal-title":"Turk J Med Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16801","article-title":"Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies","volume":"190","author":"Mart\u00edn-Moro F","year":"2020","unstructured":"Mart\u00edn-Moro F, Marquet J, Piris M, et al.. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol. 2020, 190:e16-20. 10.1111\/bjh.16801","journal-title":"Br J Haematol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164896","article-title":"COVID-19-related ARDS: key mechanistic features and treatments","volume":"11","author":"Selickman J","year":"2022","unstructured":"Selickman J, Vrettou CS, Mentzelopoulos SD, Marini JJ. COVID-19-related ARDS: key mechanistic features and treatments. J Clin Med. 2022, 11:4896. 10.3390\/jcm11164896","journal-title":"J Clin Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2020.07.005","article-title":"The risk and prognosis of COVID-19 infection in cancer patients: a systematic review and meta-analysis","volume":"15","author":"ElGohary GM","year":"2022","unstructured":"ElGohary GM, Hashmi S, Styczynski J, et al.. The risk and prognosis of COVID-19 infection in cancer patients: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther. 2022, 15:45-53. 10.1016\/j.hemonc.2020.07.005","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intcar.2020.100004","article-title":"COVID-19 disease: invasive ventilation","volume":"1","author":"Carter C","year":"2020","unstructured":"Carter C, Osborn M, Agagah G, Aedy H, Notter J. COVID-19 disease: invasive ventilation. Clin Int Care. 2020, 1:100004. 10.1016\/j.intcar.2020.100004","journal-title":"Clin Int Care"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158081","article-title":"Acute kidney injury in COVID-19","volume":"22","author":"G\u0142owacka M","year":"2021","unstructured":"G\u0142owacka M, Lipka S, M\u0142ynarska E, Franczyk B, Rysz J. Acute kidney injury in COVID-19. Int J Mol Sci. 2021, 22:8081. 10.3390\/ijms22158081","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2013.07.004","article-title":"Kidney involvement in leukemia and lymphoma","volume":"21","author":"Luciano RL","year":"2014","unstructured":"Luciano RL, Brewster UC. Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis. 2014, 21:27-35. 10.1053\/j.ackd.2013.07.004","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen L","year":"2020","unstructured":"Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020, 116:1097-100. 10.1093\/cvr\/cvaa078","journal-title":"Cardiovasc Res"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317186","article-title":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?","volume":"106","author":"Imazio M","year":"2020","unstructured":"Imazio M, Klingel K, Kindermann I, Brucato A, De Rosa FG, Adler Y, De Ferrari GM. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?. Heart. 2020, 106:1127-31. 10.1136\/heartjnl-2020-317186","journal-title":"Heart"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1714275","article-title":"Thrombosis and hemostasis issues in cancer patients with COVID-19","volume":"46","author":"Horowitz NA","year":"2020","unstructured":"Horowitz NA, Brenner B. Thrombosis and hemostasis issues in cancer patients with COVID-19. Semin Thromb Hemost. 2020, 46:785-8. 10.1055\/s-0040-1714275","journal-title":"Semin Thromb Hemost"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06785-2","article-title":"Coronavirus seasonality, respiratory infections and weather","volume":"21","author":"Nichols GL","year":"2021","unstructured":"Nichols GL, Gillingham EL, Macintyre HL, et al.. Coronavirus seasonality, respiratory infections and weather. BMC Infect Dis. 2021, 21:1101. 10.1186\/s12879-021-06785-2","journal-title":"BMC Infect Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.3066","article-title":"Deaths due to COVID-19 in patients with cancer during different waves of the pandemic in the US","volume":"9","author":"Potter AL","year":"2023","unstructured":"Potter AL, Vaddaraju V, Venkateswaran S, et al.. Deaths due to COVID-19 in patients with cancer during different waves of the pandemic in the US. JAMA Oncol. 2023, 9:1417-22. 10.1001\/jamaoncol.2023.3066","journal-title":"JAMA Oncol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2263349","article-title":"Monthly variations in acute coronary syndromes outcomes during the first year of the COVID-19 pandemic","volume":"39","author":"Alharbi A","year":"2023","unstructured":"Alharbi A, Alfatlawi H, Pena C, et al.. Monthly variations in acute coronary syndromes outcomes during the first year of the COVID-19 pandemic. Curr Med Res Opin. 2023, 39:1419-24. 10.1080\/03007995.2023.2263349","journal-title":"Curr Med Res Opin"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70166","article-title":"Current updates on variants of SARS-CoV-2: systematic review","volume":"7","author":"Erkihun M","year":"2024","unstructured":"Erkihun M, Ayele B, Asmare Z, Endalamaw K. Current updates on variants of SARS-CoV-2: systematic review. Health Sci Rep. 2024, 7:e70166. 10.1002\/hsr2.70166","journal-title":"Health Sci Rep"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.9609","article-title":"Association of Omicron vs wild-type SARS-CoV-2 variants with hospital-onset SARS-CoV-2 infections in a US regional hospital system","volume":"328","author":"Klompas M","year":"2022","unstructured":"Klompas M, Pandolfi MC, Nisar AB, Baker MA, Rhee C. Association of Omicron vs wild-type SARS-CoV-2 variants with hospital-onset SARS-CoV-2 infections in a US regional hospital system. JAMA. 2022, 328:296-8. 10.1001\/jama.2022.9609","journal-title":"JAMA"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of COVID-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee AR","year":"2022","unstructured":"Lee AR, Wong SY, Chai LY, et al.. Efficacy of COVID-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ. 2022, 376:e068632. 10.1136\/bmj-2021-068632","journal-title":"BMJ"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-141327","article-title":"Outcomes of patients with hematologic malignancies and COVID-19 infection: a report from the ASH Research Collaborative data hub","volume":"136","author":"Wood WA","year":"2021","unstructured":"Wood WA, Neuberg DS, Thompson JC, et al.. Outcomes of patients with hematologic malignancies and COVID-19 infection: a report from the ASH Research Collaborative data hub. Blood. 2021, 136:7-8. 10.1182\/blood-2020-141327","journal-title":"Blood"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01030-2","article-title":"Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia","volume":"34","author":"Roeker LE","year":"2020","unstructured":"Roeker LE, Knorr DA, Pessin MS, et al.. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. Leukemia. 2020, 34:3047-9. 10.1038\/s41375-020-01030-2","journal-title":"Leukemia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367747-factors-associated-with-mortality-in-leukemia-and-lymphoma-with-covid-19-a-national-inpatient-sample-analysis-2020-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T14:23:43Z","timestamp":1750602223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367747-factors-associated-with-mortality-in-leukemia-and-lymphoma-with-covid-19-a-national-inpatient-sample-analysis-2020-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,22]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.86534","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,22]]}}}